This move is archived. Current quotes and coverage live on the stock page.
Get MBX alerts:
Microbix Biosystems Inc. is on the rise, closing up 1.79% in the latest trading session.
Microbix Biosystems Inc. (MBX.TO) has seen a positive shift in its stock price, gaining 1.79% in the last trading session. This uptick comes amidst ongoing developments in the biotech sector, suggesting potential investor optimism.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$42.46M
52W high
$0.33
52W low
$0.21
1W change
+0.00%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 37.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+37.9% Upside
Current Price
C$0.29
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
57.1%
Annualized
90-Day Vol
53.4%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.29
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.29 | C$0.24 โ C$0.35 |
| 60 trading days | C$0.29 | C$0.22 โ C$0.38 |
| 90 trading days | C$0.29 | C$0.21 โ C$0.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With a market cap of CA$38.5 million, Microbix is a small-cap player in the biotech space, and its recent performance may indicate growing investor confidence ahead of its upcoming financial results.
Microbix Biosystems Inc. Market Cap Hits CA$38.5 Million
With a market cap of CA$38.5 million, Microbix remains a small player in the biotech industry, making its stock movements particularly sensitive to market sentiment and news.
Bull case
The recent increase in stock price could signal positive market sentiment towards Microbix, especially as it prepares to release its Q1 2026 financial results. The company reported a 13% revenue increase in the previous quarter, which might encourage more investment.
Bear case
Despite the recent gains, Microbix still faces challenges, including a significant net loss of -38.62%. Investors should stay cautious as the company navigates its financial landscape and prepares for upcoming earnings reports.
Recent Performance Overview
Advertisement
Microbix Biosystems Inc. closed at CA$0.28 after a 1.79% increase in the latest trading session. This gain reflects a broader interest in biotech stocks, particularly as the company gears up to announce its Q1 2026 results.
Looking Ahead: Financial Results on the Horizon
Investors are eagerly awaiting the release of Microbix's Q1 2026 financial results on February 12, 2026. The company has previously reported a 13% increase in revenues, which could boost investor confidence if trends continue.
Market Sentiment and Future Prospects
While the recent stock gain is promising, Microbix's ongoing challenges, including a significant net loss, remind investors to approach with caution. The upcoming financial results will be crucial in determining the company's trajectory in the competitive biotech landscape.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
